BioUtah COVID-19 Life Sciences Survey
March 17, 2020
TIME SENSITIVE – PLEASE TAKE SURVEY
Dear Members of Utah’s Life Sciences Community,
BioUtah is taking a multi-pronged approach to support our life sciences companies, industry workforce, and communities during the COVID-19 pandemic, including:
- Working directly with the Utah State Coronavirus Task Force to identify products and resources needed in the state
- Indentifing funding sources from state and federal governments to support emergency countermeasures and other responses
- Gaining a better understanding of how our companies are impacted and how BioUtah can provide assistance
We ask you to respond to a brief survey by Friday, March 20.
Recent News
- Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting
- BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease
- Lessons in Innovation: Clark Turner’s Impact on Medical Imaging
- Merit Medical Acquires Biolife Delaware
- Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI
- BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies
